# Collagen Matrix acquires Polyganics

Collagen Matrix, Inc., a Linden Capital Partners portfolio company, acquired Polyganics, B.V., a medical technology company developing bioresorbable medical devices. The acquisition expands Collagen Matrix's portfolio.

- Type: Acquisition
- Announced: 2022-10-05
- Where: Netherlands
- Jobs: 75
- Status: completed
- Products: bioresorbable medical devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Linden Capital Partners](https://endata.com/companies/20305.md) (investor)
- [Collagen Matrix](https://endata.com/companies/52190.md) (acquirer)
- [Polyganics](https://endata.com/companies/65762.md) (target)

## Sources

- [polyganics.com](https://polyganics.com/category/news/), 2022-10-05: "The acquisition expands Collagen Matrix's portfolio."
- [njbiz.com](https://njbiz.com/collagen-matrix-acquires-dutch-medical-technology-company/), 2022-10-07: "We’re laser focused on establishing Collagen Matrix as a global leader in regenerative medicine solutions."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.